Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccine.

Teymour, Shereen; Ahram, Aya; Blackwell, Tim; Bhate, Chinmoy; Cohen, Philip J; Whitworth, Jeffrey M

Teymour, Shereen; Ahram, Aya; Blackwell, Tim; Bhate, Chinmoy; Cohen, Philip J; Whitworth, Jeffrey M.

Teymour S; Palisades Dermatology Residency Program, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Ahram A; Palisades Dermatology Residency Program, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Blackwell T; School of Osteopathic Medicine, Rowan University, Stratford, New Jersey, USA.
Bhate C; Dermatology, Pathology and Lab Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Cohen PJ; Dermatology, Veterans Affairs New Jersey Health Care System, Lyons, New Jersey, USA.
Whitworth JM; Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

Dermatol Ther ; 35(4): e15302, 2022 04.

Article in English | MEDLINE | ID: covidwho-1608230

Subject(s)

COVID-19; Erythema Nodosum; 2019-nCoV Vaccine mRNA-1273; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Erythema Nodosum/diagnosis; Erythema Nodosum/etiology; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Erythema Nodosum / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15302

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google